首页> 美国卫生研究院文献>Journal of Experimental Clinical Cancer Research : CR >Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice
【2h】

Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice

机译:姜黄素通过损害AMPK / ULK1依赖性自噬AKT活性并增强结肠癌细胞的凋亡并抑制异种移植小鼠的肿瘤生长而与5-氟尿嘧啶协同作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundChemoresistance is a major obstacle that limits the benefits of 5-Fluorouracil (5-Fu)-based chemotherapy for colon cancer patients. Autophagy is an important cellular mechanism underlying chemoresistance. Recent research advances have given new insights into the use of natural bioactive compounds to overcome chemoresistance in colon cancer chemotherapy. As one of the multitargeted and safer phytomedicines, curcumin has been reported to work as cancer-specific chemosensitizer, presumably via induction of autophagic signaling pathways. The precise therapeutic effect of curcumin on autophagy in determining tumorous cells’ fate, however, remains unclear. This study was conducted to investigate the differential modulations of the treatments either with 5-Fu alone or 5-Fu combined with curcumin on cellular autophagic responses and viabilities in the human colon cancer cells HCT116 and HT29, and explore molecular signaling transductions underlying the curcumin-mediated autophagic changes and potentiation of 5-Fu’s cytotoxicity in vitro and in vivo.
机译:背景化学抗性是限制基于5-氟尿嘧啶(5-Fu)的化学疗法对结肠癌患者的益处的主要障碍。自噬是化学抗性的重要细胞机制。最近的研究进展为使用天然生物活性化合物克服结肠癌化疗中的化学耐药性提供了新见识。姜黄素是一种多靶点且更安全的植物药,据报道可能通过诱导自噬信号传导途径起癌症特异性化学增敏剂的作用。姜黄素在决定肿瘤细胞命运方面对自噬的确切治疗作用尚不清楚。进行这项研究的目的是研究单独使用5-Fu或5-Fu与姜黄素联合治疗对人结肠癌细胞HCT116和HT29细胞自噬反应和活力的差异调节,并探讨姜黄素-介导的5-Fu在体外和体内的自噬变化和增强的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号